GenRx Entecavir entecavir (as monohydrate) 1mg tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

entecavir, Quantity: 1 mg

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

Entecavir

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Excipient Ingredients: lactose monohydrate; hyprolose; crospovidone; magnesium stearate; titanium dioxide; iron oxide red; microcrystalline cellulose; macrogol 8000; copovidone; hypromellose

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

30

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults 16 years or older with evidence of active liver inflammation.,This indication is based on histologic, virologic, biochemical and serological responses in nucleoside-treatment na?ve and lamivudine-resistant adult patients with HBeAg-positive or HBeAg-negative chronic HBV infection with compensated liver disease.

Sommarju tal-prodott:

Visual Identification: Pink colored, triangular shaped film coated tablets, engraved 'APO' on one side and '1' over 'ENT' on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2016-03-10